Barriers and opportunities for gemcitabine in pancreatic cancer therapy
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Physiology - Cell Physiology"
DOI: 10.1152/ajpcell.00331.2022
Abstract: Pancreatic ductal adenocarcinoma (PDA) has become one of the leading causes of cancer-related deaths across the world. A lack of durable responses to standard-of-care chemotherapies renders its treatment particularly challenging and largely contributes to the… read more here.
Keywords: barriers opportunities; therapy; opportunities gemcitabine; physiology ... See more keywords